Report cover image

Universal Diagnostics SL - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Jun 27, 2023
Length 30 Pages
SKU # GBDT18068048

Description

Summary


Universal Diagnostics SL (Universal DX) is a biomedicine company that develops blood-based screening tests for the early detection of cancer. The company develops test based on proprietary technologies and spectral analysis of metabolites. Its first pipeline product candidate is for the early detection and prevention of colorectal cancer, adenomatous polyps, colorectal lung and breast cancers. Universal DX identifies a proprietary panel of biomarkers that allows to differentiate cancer and adenoma patients from healthy individuals. The company collaborates with technological and medical institutions. It partners with several biobanks and hospitals. Universal DX is headquartered in Sevilla, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Universal Diagnostics SL
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

30 Pages
Universal Diagnostics SL Company Overview
Universal Diagnostics SL Company Snapshot
Universal Diagnostics SL Pipeline Products and Ongoing Clinical Trials Overview
Universal Diagnostics SL – Pipeline Analysis Overview
Universal Diagnostics SL - Key Facts
Universal Diagnostics SL - Major Products and Services
Universal Diagnostics SL Pipeline Products by Development Stage
Universal Diagnostics SL Ongoing Clinical Trials by Trial Status
Universal Diagnostics SL Pipeline Products Overview
Blood-Based Diagnostic Test - Breast Cancer
Blood-Based Diagnostic Test - Breast Cancer Product Overview
Blood-Based Diagnostic Test - Colorectal Cancer
Blood-Based Diagnostic Test - Colorectal Cancer Product Overview
Blood-Based Diagnostic Test - Lung Cancer
Blood-Based Diagnostic Test - Lung Cancer Product Overview
Multi-Cancer Detection Test
Multi-Cancer Detection Test Product Overview
Signal-C
Signal-C Product Overview
Signal-C Clinical Trial
Signal-G
Signal-G Product Overview
Signal-L
Signal-L Product Overview
Signal-P
Signal-P Product Overview
Signal-X
Signal-X Product Overview
Universal Diagnostics SL - Key Competitors
Universal Diagnostics SL - Key Employees
Universal Diagnostics SL - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Universal Diagnostics SL, Recent Developments
Nov 17, 2022: Universal DX presents methylation biomarker data at AACR special conference: precision prevention, early detection, and interception of cancer
Jun 03, 2021: Cancer prevention and early detection are one step closer as Universal DX announces breakthrough study results from its Multi-Omics + Computational Biology + ML Blood test
Nov 20, 2017: Universal Diagnostics Starts Clinical Study of Novel Blood Screening Test for Early Detection of Colon Cancer with Imperial College Healthcare NHS Trust
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Universal Diagnostics SL Pipeline Products and Ongoing Clinical Trials Overview
Universal Diagnostics SL Pipeline Products by Equipment Type
Universal Diagnostics SL Pipeline Products by Indication
Universal Diagnostics SL Ongoing Clinical Trials by Trial Status
Universal Diagnostics SL, Key Facts
Universal Diagnostics SL, Major Products and Services
Universal Diagnostics SL Number of Pipeline Products by Development Stage
Universal Diagnostics SL Pipeline Products Summary by Development Stage
Universal Diagnostics SL Ongoing Clinical Trials by Trial Status
Universal Diagnostics SL Ongoing Clinical Trials Summary
Blood-Based Diagnostic Test - Breast Cancer - Product Status
Blood-Based Diagnostic Test - Breast Cancer - Product Description
Blood-Based Diagnostic Test - Colorectal Cancer - Product Status
Blood-Based Diagnostic Test - Colorectal Cancer - Product Description
Blood-Based Diagnostic Test - Lung Cancer - Product Status
Blood-Based Diagnostic Test - Lung Cancer - Product Description
Multi-Cancer Detection Test - Product Status
Multi-Cancer Detection Test - Product Description
Signal-C - Product Status
Signal-C - Product Description
Signal-C - Collection of Samples from the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance (USOPTIVAL)
Signal-G - Product Status
Signal-G - Product Description
Signal-L - Product Status
Signal-L - Product Description
Signal-P - Product Status
Signal-P - Product Description
Signal-X - Product Status
Signal-X - Product Description
Universal Diagnostics SL, Key Employees
Universal Diagnostics SL, Other Locations
Glossary
List of Figures
Universal Diagnostics SL Pipeline Products by Equipment Type
Universal Diagnostics SL Pipeline Products by Development Stage
Universal Diagnostics SL Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us